R. Hollis

M. Pfaller, R. Jones, P. Winokur, 2000, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

Strain variation among and antifungal susceptibilities of isolates of Candida krusei

M. Pfaller, R. Hollis, Y. Berrouane, 1996, Journal of clinical microbiology.

Recurrent gram-negative bacteremia: incidence and clinical patterns.

R. Wenzel, M. Pfaller, L. Herwaldt, 1999, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Molecular epidemiology of gastric colonization by Enterococcus faecalis in a surgical intensive care unit.

M. Pfaller, R. Hollis, K. Ephgrave, 1994, Diagnostic microbiology and infectious disease.

Electrophoretic karyotype and in vitro antifungal susceptibility of Cryptococcus neoformans isolates from AIDS patients.

M. Pfaller, S. Messer, M. Rinaldi, 1995, Diagnostic microbiology and infectious disease.

Evidence of nosocomial spread of Candida albicans causing bloodstream infection in a neonatal intensive care unit.

R. Wenzel, M. Pfaller, R. Hollis, 1995, Diagnostic microbiology and infectious disease.

Variations in DNA subtype, antifungal susceptibility, and slime production among clinical isolates of Candida parapsilosis.

M. Pfaller, S. Messer, R. Hollis, 1995, Diagnostic microbiology and infectious disease.

Restriction endonuclease analysis of plasmid DNA from methicillin-resistant Staphylococcus aureus: clinical application over a three-year period.

R. Wenzel, M. Nettleman, R. Hollis, 1993 .

In Vitro Activities of Voriconazole, Posaconazole, and Four Licensed Systemic Antifungal Agents against Candida Species Infrequently Isolated from Blood

M. Pfaller, D. Diekema, R. Jones, 2003, Journal of Clinical Microbiology.

Caspofungin Activity against Clinical Isolates of Fluconazole-Resistant Candida

M. Pfaller, D. Diekema, S. Messer, 2003, Journal of Clinical Microbiology.

International Surveillance of Bloodstream Infections Due toCandida Species: Frequency of Occurrence and In Vitro Susceptibilities to Fluconazole, Ravuconazole, and Voriconazole of Isolates Collected from 1997 through 1999 in the SENTRY Antimicrobial Surveillance Program

M. Pfaller, D. Diekema, R. Jones, 2001, Journal of Clinical Microbiology.

Inducible amp C beta-lactamase producing gram-negative bacilli from blood stream infections: frequency, antimicrobial susceptibility, and molecular epidemiology in a national surveillance program (SCOPE).

Ronald N. Jones, R. Wenzel, M. Edmond, 1997, Diagnostic microbiology and infectious disease.

Nosocomial enterococcal blood stream infections in the SCOPE Program: antimicrobial resistance, species occurrence, molecular testing results, and laboratory testing accuracy. SCOPE Hospital Study Group.

R. Wenzel, M. Edmond, M. Pfaller, 1997, Diagnostic microbiology and infectious disease.

Antimicrobial activity of 12 broad-spectrum agents tested against 270 nosocomial blood stream infection isolates caused by non-enteric gram-negative bacilli: occurrence of resistance, molecular epidemiology, and screening for metallo-enzymes.

M. Pfaller, R. Jones, S. Marshall, 1997, Diagnostic microbiology and infectious disease.

Familial carriage of methicillin-resistant Staphylococcus aureus and subsequent infection in a premature neonate.

B. Doebbeling, R. Wenzel, M. Pfaller, 1995, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Variations in DNA subtype and antifungal susceptibility among clinical isolates of Candida tropicalis.

M. Pfaller, R. Hollis, J. Zhang, 1997, Diagnostic microbiology and infectious disease.

A Prolonged Outbreak of Methicillin-Resistant Staphylococcus aureus in the Burn Unit of a Tertiary Medical Center

M. Pfaller, P. A. Meier, L. Herwaldt, 1996, Infection Control & Hospital Epidemiology.

Antimicrobial Activity and Spectrum Investigation of Eight Broad-Spectrum β-Lactam Drugs: A 1997 Surveillance Trial in 102 Medical Centers in the United States

Ronald N. Jones, M. Pfaller, G. Doern, 1998 .

In Vitro Activities of Ravuconazole and Voriconazole Compared with Those of Four Approved Systemic Antifungal Agents against 6,970 Clinical Isolates of Candida spp

M. Pfaller, D. Diekema, R. Jones, 2002, Antimicrobial Agents and Chemotherapy.

In Vitro Susceptibilities of CandidaBloodstream Isolates to the New Triazole Antifungal Agents BMS-207147, Sch 56592, and Voriconazole

M. Brandt, M. Pfaller, G. Doern, 1998, Antimicrobial Agents and Chemotherapy.

Variation in Susceptibility of Bloodstream Isolates of Candida glabrata to Fluconazole According to Patient Age and Geographic Location in the United States in 2001 to 2007

M. Pfaller, D. Diekema, S. Messer, 2009, Journal of Clinical Microbiology.

Variation in Susceptibility of Bloodstream Isolates of Candida glabrata to Fluconazole According to Patient Age and Geographic Location

M. Pfaller, D. Diekema, S. Messer, 2003, Journal of Clinical Microbiology.

Long-term efficacy of intranasal mupirocin ointment. A prospective cohort study of Staphylococcus aureus carriage.

B. Doebbeling, R. Wenzel, M. Pfaller, 1994, Archives of internal medicine.

Elimination of coincident Staphylococcus aureus nasal and hand carriage with intranasal application of mupirocin calcium ointment.

B. Doebbeling, R. Wenzel, M. Pfaller, 1991, Annals of internal medicine.

Evaluation of the discriminatory power of pulsed-field gel electrophoresis and PCR fingerprinting for epidemiologic typing of Candida species.

W. Melchers, J. Meis, A. Voss, 1998, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

The use of biotyping and DNA fingerprinting in typing Candida albicans from hospitalized patients.

R. Wenzel, M. Pfaller, R. Hollis, 1990, Diagnostic microbiology and infectious disease.

Comparison of expression of virulence factors by Escherichia coli causing cystitis and E. coli colonizing the periurethra of healthy girls.

T. Whittam, A. Stapleton, M. Pfaller, 1995, The Journal of infectious diseases.

Molecular epidemiology of coagulase-negative staphylococci isolated from immunocompromised patients.

M. Pfaller, L. Herwaldt, L. Boyken, 1992 .

An outbreak of Candida parapsilosis prosthetic valve endocarditis.

R. Wenzel, M. Pfaller, D. Diekema, 1997, Diagnostic microbiology and infectious disease.

Molecular epidemiology of an outbreak of meningococcal disease in a university community

R. Wenzel, M. Edmond, A. Houston, 1995, Journal of clinical microbiology.

Restriction Endonuclease Analysis of Plasmid DNA From Methicillin-Resistant Staphylococcus aureus: Clinical Application Over a Three-Year Period

R. Wenzel, M. Nettleman, M. Pfaller, 1993, Infection Control & Hospital Epidemiology.

Comparison of an Automated Ribotyping System to Restriction Endonuclease Analysis and Pulsed-Field Gel Electrophoresis for Differentiating Vancomycin-Resistant Enterococcus faecium Isolates

L. Peterson, G. Noskin, M. Pfaller, 2002, Journal of Clinical Microbiology.

Comparative evaluation of an automated ribotyping instrument versus pulsed-field gel electrophoresis for epidemiological investigation of clinical isolates of bacteria.

M. Pfaller, R. Hollis, J. Bruce, 1999, Diagnostic microbiology and infectious disease.

Investigation of Candida albicans transmission in a surgical intensive care unit cluster by using genomic DNA typing methods

B. Doebbeling, A. Voss, M. Pfaller, 1995, Journal of clinical microbiology.

Restriction fragment analysis of a Candida tropicalis outbreak of sternal wound infections

B. Doebbeling, R. Wenzel, M. Pfaller, 1991, Journal of clinical microbiology.

Outbreak of Candida rugosa candidemia: an emerging pathogen that may be refractory to amphotericin B therapy.

R. Salomão, M. Pfaller, M. Briones, 2003, Diagnostic microbiology and infectious disease.

Trends in species distribution and susceptibility to fluconazole among blood stream isolates of Candida species in the United States.

M. Brandt, M. Pfaller, G. Doern, 1999, Diagnostic microbiology and infectious disease.

Methicillin-Resistant Staphylococcus aureus Outbreak in a Veterinary Teaching Hospital: Potential Human-to-Animal Transmission

Ronald N. Jones, W. Kloos, J. Caron, 1999, Journal of Clinical Microbiology.

Staphylococcus aureus colonization and infection in patients on continuous ambulatory peritoneal dialysis

L. Herwaldt, R. Sesso, R. Hollis, 1990, Journal of clinical microbiology.

using genomic DNA typing methods. in a surgical intensive care unit cluster by Investigation of Candida albicans transmission

A. Voss, M. Pfaller, R. Hollis, 2013 .

Molecular epidemiology of gram-negative bacteremia.

R. Wenzel, M. Pfaller, L. Herwaldt, 1999, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Vertical and horizontal transmission of unique Candida species to premature newborns.

R. Wenzel, M. Pfaller, J. Ferguson, 1996, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Comparison of pulsed-field gel electrophoresis with isoenzyme profiles as a typing system for Candida tropicalis.

B. Doebbeling, A. Widmer, A. Voss, 1993, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Improving typeability of multiple bacterial species using pulsed-field gel electrophoresis and thiourea.

M. Pfaller, R. Hollis, L. Boyken, 2003, Diagnostic microbiology and infectious disease.

Molecular Epidemiology of Extended-Spectrum β-Lactamase-Producing, Fluoroquinolone-Resistant Isolates of Klebsiella pneumoniae in Taiwan

M. Pfaller, R. Jones, S. Messer, 2002, Journal of Clinical Microbiology.

Transmission of Citrobacter koseri from mother to infant documented by ribotyping and pulsed-field gel electrophoresis.

M. Pfaller, S. Coffman, R. Hollis, 1996, Diagnostic microbiology and infectious disease.

The use of molecular techniques in the epidemiology and control of infectious diseases.

M. Pfaller, R. Hollis, H. Sader, 1995, Clinics in laboratory medicine.

Comparison of Results of Voriconazole Disk Diffusion Testing for Candida Species with Results from a Central Reference Laboratory in the ARTEMIS Global Antifungal Surveillance Program

M. Pfaller, D. Diekema, S. Messer, 2005, Journal of Clinical Microbiology.

Molecular epidemiology and antimicrobial susceptibility testing. Testing of quinolone-resistant Staphylococcus aureus strains isolated in Brazil.

M. Pfaller, R. Jones, R. Hollis, 1993, Diagnostic microbiology and infectious disease.

Activities of Fluconazole and Voriconazole against 1,586 Recent Clinical Isolates of Candida Species Determined by Broth Microdilution, Disk Diffusion, and Etest Methods: Report from The ARTEMIS Global Antifungal Susceptibility Program, 2001

M. Pfaller, D. Diekema, S. Messer, 2003, Journal of Clinical Microbiology.

In Vitro Susceptibility of Clinical Isolates of Aspergillus spp. to Anidulafungin, Caspofungin, and Micafungin: a Head-to-Head Comparison Using the CLSI M38-A2 Broth Microdilution Method

M. Pfaller, D. Diekema, S. Messer, 2009, Journal of Clinical Microbiology.

Change in Colony Morphology of Candida lusitaniae in Association with Development of Amphotericin B Resistance

E. Baron, M. Pfaller, A. Gales, 2002, Antimicrobial Agents and Chemotherapy.

In Vitro Activity of Seven Systemically Active Antifungal Agents against a Large Global Collection of Rare Candida Species as Determined by CLSI Broth Microdilution Methods

M. Pfaller, D. Diekema, S. Messer, 2009, Journal of Clinical Microbiology.

Global Trends in the Antifungal Susceptibility of Cryptococcus neoformans (1990 to 2004)

M. Pfaller, G. Doern, D. Diekema, 2005, Journal of Clinical Microbiology.

In vitro activities of voriconazole, posaconazole, and fluconazole against 4,169 clinical isolates of Candida spp. and Cryptococcus neoformans collected during 2001 and 2002 in the ARTEMIS global antifungal surveillance program.

M. Pfaller, D. Diekema, S. Messer, 2004, Diagnostic microbiology and infectious disease.

In vitro susceptibilities of rare Candida bloodstream isolates to ravuconazole and three comparative antifungal agents.

M. Pfaller, D. Diekema, R. Jones, 2004, Diagnostic microbiology and infectious disease.

In Vitro Activities of Caspofungin Compared with Those of Fluconazole and Itraconazole against 3,959 Clinical Isolates of Candida spp., Including 157 Fluconazole-Resistant Isolates

M. Pfaller, D. Diekema, R. Jones, 2003, Antimicrobial Agents and Chemotherapy.

THE REGULATION OF Na PUMP-MEDIATED ATP: ADP EXCHANGE BY EXTRACELLULAR Na IONS

J. Kaplan, M. Mone, R. Hollis, 1981 .

External Na dependence of ouabain-sensitive ATP: ADP exchange initiated by photolysis of intracellular caged-ATP in human red cell ghosts

J. Kaplan, R. Hollis, 1980, Nature.

Antifungal susceptibility of South African oral yeast isolates from HIV/AIDS patients and healthy individuals.

M. Pfaller, S. Messer, R. Hollis, 2002, Diagnostic microbiology and infectious disease.

In Vitro Activities of Posaconazole (Sch 56592) Compared with Those of Itraconazole and Fluconazole against 3,685 Clinical Isolates of Candida spp. andCryptococcus neoformans

M. Pfaller, R. Jones, S. Messer, 2001, Antimicrobial Agents and Chemotherapy.

Use of Fluconazole as a Surrogate Marker To Predict Susceptibility and Resistance to Voriconazole among 13,338 Clinical Isolates of Candida spp. Tested by Clinical and Laboratory Standards Institute-Recommended Broth Microdilution Methods

M. Pfaller, D. Diekema, S. Messer, 2006, Journal of Clinical Microbiology.

Use of Fluconazole as a Surrogate Marker To Predict Susceptibility and Resistance to Voriconazole among 13,338 Clinical Isolates of Candida spp. Tested by Clinical and Laboratory Standards Methods

M. Pfaller, S. Messer, S. Tendolkar, 2006 .

Geographic Variation in the Susceptibilities of Invasive Isolates of Candida glabrata to Seven Systemically Active Antifungal Agents: a Global Assessment from the ARTEMIS Antifungal Surveillance Program Conducted in 2001 and 2002

M. Pfaller, D. Diekema, S. Messer, 2004, Journal of Clinical Microbiology.

In Vitro Activities of 5-Fluorocytosine against 8,803 Clinical Isolates of Candida spp.: Global Assessment of Primary Resistance Using National Committee for Clinical Laboratory Standards Susceptibility Testing Methods

M. Pfaller, D. Diekema, S. Messer, 2002, Antimicrobial Agents and Chemotherapy.

Characterization of Heteroresistance to Fluconazole among Clinical Isolates of Cryptococcus neoformans

M. Pfaller, R. Jones, S. Messer, 2003, Journal of Clinical Microbiology.

Transmission of fluconazole-resistant Candida albicans between patients with AIDS and oropharyngeal candidiasis documented by pulsed-field gel electrophoresis.

M. Del Poeta, M. Pfaller, M. Rinaldi, 1995, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

DNA subtypes and fluconazole susceptibilities of Candida albicans isolates from the oral cavities of patients with AIDS.

M. Pfaller, M. Rinaldi, F. Barchiesi, 1995, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Molecular Epidemiology of Coagulase-Negative Staphylococci Isolated From Immunocompromised Patients

M. Pfaller, L. Herwaldt, L. Boyken, 1992, Infection Control & Hospital Epidemiology.

Global Surveillance of In Vitro Activity of Micafungin against Candida: a Comparison with Caspofungin by CLSI-Recommended Methods

M. Pfaller, D. Diekema, S. Messer, 2006, Journal of Clinical Microbiology.

In vitro susceptibility testing and DNA typing of Saccharomyces cerevisiae clinical isolates

M. Pfaller, R. Hollis, M. Pfaller, 1996, Journal of clinical microbiology.

Cross-Resistance between Fluconazole and Ravuconazole and the Use of Fluconazole as a Surrogate Marker To Predict Susceptibility and Resistance to Ravuconazole among 12,796 Clinical Isolates of Candida spp

M. Pfaller, D. Diekema, S. Messer, 2004, Journal of Clinical Microbiology.

Antifungal Susceptibilities of Candida Species Causing Vulvovaginitis and Epidemiology of Recurrent Cases

Sandra S. Richter, S. Richter, M. Pfaller, 2005, Journal of Clinical Microbiology.

In Vitro Susceptibilities of Clinical Isolates of Candida Species, Cryptococcus neoformans, and Aspergillus Species to Itraconazole: Global Survey of 9,359 Isolates Tested by Clinical and Laboratory Standards Institute Broth Microdilution Methods

M. Pfaller, D. Diekema, S. Messer, 2005, Journal of Clinical Microbiology.

Epidemiologic typing of multiply drug-resistant Pseudomonas aeruginosa isolated from an outbreak in an intensive care unit.

M. Burattini, R. Jones, R. Hollis, 1993, Diagnostic microbiology and infectious disease.

In Vitro Activities of Ravuconazole (BMS-207147) against 541 Clinical Isolates of Cryptococcus neoformans

M. Pfaller, R. Jones, S. Messer, 2000, Antimicrobial Agents and Chemotherapy.

Selection of a Surrogate Agent (Fluconazole or Voriconazole) for Initial Susceptibility Testing of Posaconazole against Candida spp.: Results from a Global Antifungal Surveillance Program

M. Pfaller, D. Diekema, S. Messer, 2007, Journal of Clinical Microbiology.

In Vitro Survey of Triazole Cross-Resistance among More than 700 Clinical Isolates of Aspergillus Species

M. Pfaller, D. Diekema, S. Messer, 2008, Journal of Clinical Microbiology.

Candida tropicalis vertebral osteomyelitis: a late sequela of fungemia.

B. Doebbeling, R. Gingrich, M. Pfaller, 1994, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Multisite reproducibility of MIC results by the Sensititre YeastOne colorimetric antifungal susceptibility panel.

M. Ghannoum, M. Pfaller, S. Messer, 1998, Diagnostic microbiology and infectious disease.

In Vitro Activities of BMS-207147 against Over 600 Contemporary Clinical Bloodstream Isolates of Candida Species from the SENTRY Antimicrobial Surveillance Program in North America and Latin America

M. Pfaller, G. Doern, D. Diekema, 1999, Antimicrobial Agents and Chemotherapy.

Antifungal Activities of Posaconazole, Ravuconazole, and Voriconazole Compared to Those of Itraconazole and Amphotericin B against 239 Clinical Isolates of Aspergillus spp. and Other Filamentous Fungi: Report from SENTRY Antimicrobial Surveillance Program, 2000

M. Pfaller, R. Jones, S. Messer, 2002, Antimicrobial Agents and Chemotherapy.

Donor-to-host transmission of Candida albicans after corneal transplantation.

M. Pfaller, J. Sutphin, R. Hollis, 2002, American journal of ophthalmology.

Comparison of the Broth Microdilution Methods of the European Committee on Antimicrobial Susceptibility Testing and the Clinical and Laboratory Standards Institute for Testing Itraconazole, Posaconazole, and Voriconazole against Aspergillus Isolates

M. Pfaller, D. Diekema, S. Messer, 2011, Journal of Clinical Microbiology.

Wild-type minimum effective concentration distributions and epidemiologic cutoff values for caspofungin and Aspergillus spp. as determined by Clinical and Laboratory Standards Institute broth microdilution methods.

M. Pfaller, D. Diekema, S. Messer, 2010, Diagnostic microbiology and infectious disease.

In Vitro Susceptibility of Invasive Isolates of Candida spp. to Anidulafungin, Caspofungin, and Micafungin: Six Years of Global Surveillance

M. Pfaller, D. Diekema, S. Messer, 2008, Journal of Clinical Microbiology.

Stenotrophomonas maltophilia: emergence of multidrug-resistant strains during therapy and in an in vitro pharmacodynamic chamber model

D. E. Anderson, K. Carroll, J. Anderson, 1996, Antimicrobial agents and chemotherapy.

Bloodstream Infections Due to Candida Species: SENTRY Antimicrobial Surveillance Program in North America and Latin America, 1997-1998

Ronald N. Jones, M. Pfaller, G. Doern, 2000, Antimicrobial Agents and Chemotherapy.

Candida zeylanoides: another opportunistic yeast

H. Isenberg, R. Hollis, D. Levenson, 1991, Journal of clinical microbiology.

Comparison of Results of Fluconazole Disk Diffusion Testing for Candida Species with Results from a Central Reference Laboratory in the ARTEMIS Global Antifungal Surveillance Program

M. Pfaller, D. Diekema, S. Messer, 2004, Journal of Clinical Microbiology.

Trends in Antifungal Susceptibility of Candida spp. Isolated from Pediatric and Adult Patients with Bloodstream Infections: SENTRY Antimicrobial Surveillance Program, 1997 to 2000

M. Pfaller, D. Diekema, R. Jones, 2002, Journal of Clinical Microbiology.

A global evaluation of voriconazole activity tested against recent clinical isolates of Candida spp.

Ronald N. Jones, M. Pfaller, D. Diekema, 2009, Diagnostic microbiology and infectious disease.

Validation of 24-Hour Posaconazole and Voriconazole MIC Readings versus the CLSI 48-Hour Broth Microdilution Reference Method: Application of Epidemiological Cutoff Values to Results from a Global Candida Antifungal Surveillance Program

M. Pfaller, D. Diekema, S. Messer, 2011, Journal of Clinical Microbiology.

Evaluation of Etest and Disk Diffusion Methods Compared with Broth Microdilution Antifungal Susceptibility Testing of Clinical Isolates of Candida spp. against Posaconazole

M. Pfaller, D. Diekema, S. Messer, 2007, Journal of Clinical Microbiology.

DNA macrorestriction profiles and antifungal susceptibility of Candida (Torulopsis) glabrata.

M. Cormican, M. Pfaller, R. Hollis, 1996, Diagnostic microbiology and infectious disease.

Evaluation of Disk Diffusion and Etest Compared to Broth Microdilution for Antifungal Susceptibility Testing of Posaconazole against Clinical Isolates of Filamentous Fungi

M. Pfaller, D. Diekema, S. Messer, 2007, Journal of Clinical Microbiology.

Clinical evaluation of a dried commercially prepared microdilution panel for antifungal susceptibility testing of five antifungal agents against Candida spp. and Cryptococcus neoformans.

M. Pfaller, D. Diekema, S. Messer, 2004, Diagnostic microbiology and infectious disease.

Evaluation of the NCCLS M44-P Disk Diffusion Method for Determining Susceptibilities of 276 Clinical Isolates of Cryptococcus neoformans to Fluconazole

M. Pfaller, D. Diekema, S. Messer, 2004, Journal of Clinical Microbiology.

Evaluation of Three Molecular Typing Techniques for Nonfermentative Gram-Negative Bacilli

M. Pfaller, R. Hollis, H. Sader, 2004, Infection Control & Hospital Epidemiology.

Food-initiated outbreak of methicillin-resistant Staphylococcus aureus analyzed by pheno- and genotyping

H. Bruining, H. Verbrugh, S. Messer, 1995, Journal of clinical microbiology.

An Outbreak of Serratia marcescens Infections Related to Contaminated Chlorhexidine

T. Perl, M. Pfaller, V. Loo, 1998, Infection Control & Hospital Epidemiology.

Application of a biotyping system and DNA restriction fragment analysis to the study of Serratia marcescens from hospitalized patients.

M. Pfaller, M. Bale, R. Hollis, 1993, Diagnostic microbiology and infectious disease.

Outbreak of severe Pseudomonas aeruginosa infections caused by a contaminated drain in a whirlpool bathtub.

L A Herwaldt, P. Rhomberg, M. Pfaller, 2000, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Persistence of Legionella Pneumophila in a Hospital's Water System: A 13-Year Survey

C. Helms, R. Wenzel, P. Rhomberg, 1999, Infection Control & Hospital Epidemiology.

Antimicrobial activity and spectrum investigation of eight broad-spectrum beta-lactam drugs: a 1997 surveillance trial in 102 medical centers in the United States. Cefepime Study Group.

M. Pfaller, G. Doern, R. Jones, 1998, Diagnostic microbiology and infectious disease.

The application of molecular and immunologic techniques to study the epidemiology of Legionella pneumophila serogroup 1.

C. Helms, R. Wenzel, W. Johnson, 1989, Diagnostic microbiology and infectious disease.

Application of restriction endonuclease analysis of chromosomal DNA in the study of Staphylococcus aureus colonization in continuous ambulatory peritoneal dialysis patients.

M. Pfaller, L. Herwaldt, R. Sesso, 1992, Diagnostic microbiology and infectious disease.

Nosocomial transmission of Serratia odorifera biogroup. 2: Case report demonstration by macrorestriction analysis of chromosomal DNA using pulsed-field gel electrophoresis.

Ronald N. Jones, T. Perl, L. Herwaldt, 1994 .

Nosocomial Transmission of Serratia odorifera Biogroup 2: Case Report Demonstration by Macrorestriction Analysis of Chromosomal DNA Using Pulsed-Field Gel Electrophoresis

Ronald N. Jones, T. Perl, L. Herwaldt, 1994, Infection Control & Hospital Epidemiology.

The clinical microbiology laboratory as an aid in infection control. The application of molecular techniques in epidemiologic studies of methicillin-resistant Staphylococcus aureus.

D. Wakefield, M. Pfaller, R. Hollis, 1991, Diagnostic microbiology and infectious disease.

Pulsed-field gel electrophoresis of restriction-digested genomic DNA and antimicrobial susceptibility of Xanthomonas maltophilia strains from Brazil, Switzerland and the USA.

R. Jones, R. Frei, R. Hollis, 1994, The Journal of antimicrobial chemotherapy.

Comparison of Genomic Methods for Differentiating Strains of Enterococcus faecium: Assessment Using Clinical Epidemiologic Data

L. Peterson, G. Noskin, M. Pfaller, 1998, Journal of Clinical Microbiology.

Evidence for Person-to-Person Transmission of Candida lusitaniae in a Neonatal Intensive-Care Unit

S. Fowler, M. Pfaller, S. Messer, 1998, Infection Control & Hospital Epidemiology.

Evaluation of Interhospital Spread of Methicillin-Resistant Staphylococcus aureus in Sao Paulo, Brazil, Using Pulsed-Field Gel Electrophoresis of Chromosomal DNA

Ronald N. Jones, R. Hollis, H. Sader, 1994, Infection Control & Hospital Epidemiology.

A Multi-Center Outbreak of Candida tropicalis Bloodstream Infections Associated with Contaminated Hemodialysis Machine Prime Buckets.

J. Boyce, M. Pfaller, B. Moore, 2021, American journal of infection control.

Use of plasmid profiles and restriction endonuclease analysis of plasmid DNA as epidemiologic and diagnostic tools in the clinical microbiology laboratory

M. Pfaller, R. Hollis, 1989 .

In Vitro Activity of Anidulafungin and Other Agents against Esophageal Candidiasis-Associated Isolates from a Phase 3 Clinical Trial

M. Pfaller, D. Diekema, S. Messer, 2010, Journal of Clinical Microbiology.

Clinical Evaluation of a Frozen Commercially Prepared Microdilution Panel for Antifungal Susceptibility Testing of Seven Antifungal Agents, Including the New Triazoles Posaconazole, Ravuconazole, and Voriconazole

M. Pfaller, D. Diekema, S. Messer, 2002, Journal of Clinical Microbiology.

Validation of 24-Hour Fluconazole MIC Readings versus the CLSI 48-Hour Broth Microdilution Reference Method: Results from a Global Candida Antifungal Surveillance Program

M. Pfaller, D. Diekema, S. Messer, 2008, Journal of Clinical Microbiology.

A Prolonged Outbreak of Methicillin-Resistant Staphylococcus aureus in the Burn Unit of a Tertiary Medical Center

M. Pfaller, P. A. Meier, L. Herwaldt, 1996, Infection Control & Hospital Epidemiology.